EGF released from human placental mesenchymal stem cells improves premature ovarian insufficiency via NRF2/HO-1 activation

Human placental mesenchymal stem cells (hPMSCs) have the ability to release cytokines and to differentiate into the three germ layers. To date, the relevance of hPMSCs for the treatment of premature ovarian insufficiency (POI) disease through the regulation of oxidative stress is still unclear. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Chenyue, Zou, Qinyan, Wu, Yifei, Lu, Jiafeng, Qian, Chunfeng, Li, Hong, Huang, Boxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041770/
https://www.ncbi.nlm.nih.gov/pubmed/32040445
http://dx.doi.org/10.18632/aging.102794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041770/
https://www.ncbi.nlm.nih.gov/pubmed/32040445
http://dx.doi.org/10.18632/aging.102794

Ejemplares similares